Efficacy and Safety of Ginkgo Biloba Pills for Coronary Heart Disease with Impaired Glucose Regulation: Study Protocol for a Series of N-of-1 Randomized, Double-Blind, Placebo-Controlled Trials.
Mingyue SunLulu ChaiFang LuYang ZhaoQingna LiBoya CuiRui GaoYue LiuPublished in: Evidence-based complementary and alternative medicine : eCAM (2018)
Ginkgo biloba preparations are widely used in cardiovascular diseases both at home and abroad due to their definite curative effect, few side effects, various dosage forms, and convenient and safe use. Diabetes mellitus is a high-risk factor for the occurrence of cardiovascular disease. Therefore, it is of great significance to control the impaired glucose regulation and slow down the development of diabetes and reduce the incidence and mortality of cardiovascular diseases. This trial is registered with ClinicalTrials.gov (ID: NCT03483779).
Keyphrases
- cardiovascular disease
- placebo controlled
- double blind
- phase iii
- phase ii
- clinical trial
- study protocol
- cardiovascular events
- type diabetes
- risk factors
- open label
- blood glucose
- phase ii study
- cardiovascular risk factors
- glycemic control
- risk assessment
- randomized controlled trial
- rectal cancer
- coronary artery disease
- metabolic syndrome
- squamous cell carcinoma
- radiation therapy